• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

胆碱酯酶抑制剂的益处：应对阿尔茨海默病的行为和神经精神症状

The benefits of cholinesterase inhibitors: managing the behavioral and neuropsychiatric symptoms of Alzheimer's disease.

作者信息

Linton Adrianne

机构信息

Department of Chronic Nursing Care, University of Texas Health Science Center of San Antonio, 7703 Floyd Curl Drive MSC 7950, San Antonio, TX, 78229-7950, USA.

出版信息

J Gerontol Nurs. 2005 Dec;31(12):4-10. doi: 10.3928/0098-9134-20051201-04.

DOI:10.3928/0098-9134-20051201-04
PMID:16375092
Abstract

Pharmacological treatment can be helpful to improve cognition, functional ability, and behavior symptoms in older adults with Alzheimer's disease, resulting in reduced caregiver burden, delayed nursing home placement, and reduced health care costs.

摘要

药物治疗有助于改善患有阿尔茨海默病的老年人的认知、功能能力和行为症状，从而减轻护理人员的负担、延迟入住养老院的时间并降低医疗保健成本。

相似文献

1
The benefits of cholinesterase inhibitors: managing the behavioral and neuropsychiatric symptoms of Alzheimer's disease.胆碱酯酶抑制剂的益处：应对阿尔茨海默病的行为和神经精神症状
J Gerontol Nurs. 2005 Dec;31(12):4-10. doi: 10.3928/0098-9134-20051201-04.
2
Reduction of behavioral disturbances and caregiver distress by galantamine in patients with Alzheimer's disease.加兰他敏可减轻阿尔茨海默病患者的行为障碍及照料者的痛苦
Am J Psychiatry. 2004 Mar;161(3):532-8. doi: 10.1176/appi.ajp.161.3.532.
3
Current treatments for Alzheimer's disease: cholinesterase inhibitors.阿尔茨海默病的现有治疗方法：胆碱酯酶抑制剂。
J Clin Psychiatry. 2003;64 Suppl 9:11-7.
4
Alzheimer disease: Non-pharmacological and pharmacological management of cognition and neuropsychiatric symptoms.阿尔茨海默病：认知及神经精神症状的非药物和药物管理
Australas Psychiatry. 2018 Aug;26(4):358-365. doi: 10.1177/1039856218766123. Epub 2018 Apr 19.
5
Cholinesterase inhibitors used in the treatment of Alzheimer's disease: the relationship between pharmacological effects and clinical efficacy.用于治疗阿尔茨海默病的胆碱酯酶抑制剂：药理作用与临床疗效之间的关系。
Drugs Aging. 2004;21(7):453-78. doi: 10.2165/00002512-200421070-00004.
6
Treatment strategies for the behavioral symptoms of Alzheimer's disease: focus on early pharmacologic intervention.阿尔茨海默病行为症状的治疗策略：聚焦早期药物干预
Pharmacotherapy. 2007 Mar;27(3):399-411. doi: 10.1592/phco.27.3.399.
7
Innovations: geriatric psychiatry: diagnosis and treatment of neuropsychiatric symptoms in Alzheimer's disease.创新：老年精神病学：阿尔茨海默病神经精神症状的诊断与治疗
Psychiatr Serv. 2006 May;57(5):617-9. doi: 10.1176/ps.2006.57.5.617.
8
Rivastigmine. A pharmacoeconomic review of its use in Alzheimer's disease.卡巴拉汀。对其用于阿尔茨海默病的药物经济学综述。
Pharmacoeconomics. 2001;19(3):303-18. doi: 10.2165/00019053-200119030-00008.
9
[Practical clinical use of therapeutic agents for Alzheimer's disease].[用于阿尔茨海默病的治疗药物的临床实际应用]
Nihon Yakurigaku Zasshi. 2007 Dec;130(6):494-8. doi: 10.1254/fpj.130.494.
10
Preliminary evidence that rivastigmine-induced inhibition of serum butyrylcholinesterase activity improves behavioral symptoms in Japanese patients with Alzheimer's disease.初步证据表明，利伐斯的明抑制血清丁酰胆碱酯酶活性可改善日本阿尔茨海默病患者的行为症状。
Geriatr Gerontol Int. 2017 Sep;17(9):1306-1312. doi: 10.1111/ggi.12865. Epub 2016 Aug 21.

引用本文的文献

1
Design, synthesis, and evaluation of 3,7-substituted coumarin derivatives as multifunctional Alzheimer's disease agents.设计、合成及 3,7-取代香豆素衍生物作为多功能阿尔茨海默病药物的评估。
J Enzyme Inhib Med Chem. 2021 Dec;36(1):1607-1621. doi: 10.1080/14756366.2021.1913137.
2
Cholinergic Hypofunction in Presbycusis-Related Tinnitus With Cognitive Function Impairment: Emerging Hypotheses.与认知功能障碍相关的老年性聋伴耳鸣中的胆碱能功能减退：新出现的假说
Front Aging Neurosci. 2018 Apr 6;10:98. doi: 10.3389/fnagi.2018.00098. eCollection 2018.